BlinkLab

BlinkLab Dividend

Dividend of BlinkLab (BB1.AX) as of Nov 15, 2026.

Dividend

0.00AUD

Last updated:

How much dividend does BlinkLab 2026 pay?

According to the latest status from November 2026, BlinkLab paid a total of 0.00 AUD per share in dividends within the last 12 months. With the current BlinkLab price of 0.59 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical BlinkLab Dividends

Historical BlinkLab Dividends
PaydateDividend

The BlinkLab Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2022
0.00 AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
0.00 AUD
Jan 1, 2026
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
Jan 1, 2028 (e)
0.00 AUD
The BlinkLab Dividend history
YEARDividendYoY
est0.00AUD—
est0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—

Is the BlinkLab Dividend Safe?

BlinkLab has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding BlinkLab's Dividend Distributions

BlinkLab’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining BlinkLab's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

BlinkLab's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in BlinkLab’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

BlinkLab Stock analysis

What does BlinkLab do? BlinkLab Ltd offers the BlinkLab Dx system, comprising the BlinkLab App and BlinkLab Portal, to conduct neurobehavioral tests for diagnosing neurological disorders. The BlinkLab App enables patients, caregivers, and parents to complete tests in real time, while the BlinkLab Portal provides secure database management, CMS, and tools for customizing neurometric tests, data analysis, and visualization. The company generates revenue through the sale of these products to healthcare providers, research institutions, and clinics seeking cost-effective diagnostic solutions for neurological and psychiatric conditions. The BlinkLab Tests, including eyeblink conditioning (EBC), prepulse inhibition of acoustic startle (PPI), and habituation of eye blink response, serve as biomarkers for such disorders, making the system valuable for early detection and monitoring. Healthcare providers, research institutions, and clinics purchase the BlinkLab Dx system to integrate objective neurobehavioral testing into their diagnostic workflows. The BlinkLab App collects real-time data from test subjects, and the BlinkLab Portal allows for comprehensive data management and analysis, supporting both clinical and research applications. The company’s focus on biomarkers like EBC, PPI, and habituation of eye blink response positions it as a key tool for diagnosing disorders such as schizophrenia, ADHD, and autism spectrum disorders, which are increasingly recognized in clinical practice. The BlinkLab Tests, including eyeblink conditioning (EBC), prepulse inhibition of acoustic startle (PPI), and habituation of eye blink response, are marketed as objective biomarkers for neurological and psychiatric disorders. By leveraging mobile technology, BlinkLab Ltd provides a cost-effective alternative to traditional diagnostic methods, appealing to institutions looking to streamline their diagnostic processes. The company’s revenue model relies on selling the BlinkLab App and Portal as integrated solutions, with no mention of additional services or third-party partnerships in the business description. BlinkLab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BlinkLab stock

BlinkLab paid dividends every year for the past 0 years.

BlinkLab is assigned to the 'Health' sector.

The dividends of BlinkLab are distributed in AUD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — BlinkLab